forms, especially non-CDT isoforms, is unlikely.
The sixth, and final, argument is that as an analyte, asialotransferrin can simplify the production of a specific antibody for a direct assay. With a complete lack of both transferrin N-glycans (2, 10, 11 ) , the structure of asialotransferrin is different from the structure(s) of the non-CDT isoforms. Thus, there is the possibility of raising a specific antibody that binds strongly to the analyte (asialotransferrin), e.g., to an epitope near or at the original point of attachment of the carbohydrate chain(s). The availability of such an antibody against asialotransferrin would make a direct assay (without microcolumn fractionation of asialotransferrin from the other transferrin isoforms, as is currently needed for CDT and non-CDT fractionation by most of the commercial CDT assays) more probable. This would be an important step toward automation of CDT (or, more precisely, asialotransferrin) analysis.
Regardless of whether CDT or asialotransferrin is used for laboratory diagnosis of chronic alcohol abuse, the diagnosis should always be made based on inclusion of a clinical questionnaire and ␥-glutamyltransferase, and not on a single CDT value alone. Strategies for increasing the reliability of CDT results by use of a screening and confirmatory method have been discussed recently in this journal (14 ). 
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Modification of the Colorimetric Assay for Serum Unsaturated Ironbinding Capacity
To the Editor:
We reported recently that total ironbinding capacity (TIBC) values calculated from serum iron and unsaturated iron-binding capacity (UIBC) values were significantly lower than those obtained by a direct and fully automated TIBC assay (1, 2 ) . We also reported that slopes of regression lines for calculated TIBC values plotted against serum transferrin (TRF) were ϳ7% lower than the theoretical ratio of TIBC to TRF (TIBC/TRF ϭ 25.1 mol/g). We found that this could be attributed to underestimation of UIBC values by colorimetric methods. One possible reason for underestimation of UIBC values was insufficient saturation of TRF. We modified the assay conditions of a colorimetric method for UIBC measurement to improve the correspondence between TIBC values converted from TRF and those calculated from serum iron and UIBC.
Both serum iron and UIBC were determined by colorimetric methods (Wako Pure Chemical Industries) with a Hitachi Model 7070 automated analyzer. Serum TRF concentrations were determined by a nephelometric assay on a Behring Nephelometer II analyzer (Dade Behring). UIBC values were determined by four modified methods (Table 1) . UIBC A was measured by the original method, in which assay conditions were set by the manufacturer. Incubation time for saturation of TRF was extended from 5 min to 10 min for the measurement of UIBC B . The ratio of iron provided to saturate TRF per serum sample (iron/serum) was increased from 0.195 mol/L to 0.26 mol/L for the measurement of UIBC C by decreasing sample volume from 20 L to 15 L. Finally, both incubation and the iron/serum ratio were increased for the measurement of UIBC D Comparisons of the Cal-TIBC values and Con-TIBC and TRF concentrations are shown in Table 1 . The within-run CVs for the modified UIBC assays were 2.6 -3.9%. The values obtained by the UIBC B method and the UIBC D method were significantly higher than those obtained by the UIBC A method (P Ͻ0.001), whereas there was no significant difference between the values obtained by the UIBC A method and the UIBC C method (P ϭ 0.893). The Cal-TIBC B and Cal-TIBC D values were significantly higher than the Cal-TIBC A values (P Ͻ0.001), whereas there was no significant difference between the Cal-TIBC A and Cal-TIBC C values (P ϭ 0. The rate of iron binding to TRF is affected by factors such as reaction temperature, pH, ionic strength, and anions. It has been reported that TRF binds iron with HCO 3 Ϫ as a coligand in the presence of O 2 and that the concentrations of HCO 3 Ϫ and O 2 affect the kinetics of the binding process (3 ). Insufficient saturation of TRF by the effects of these factors leads to underestimation of the UIBC value.
The UIBC B values were significantly higher than the UIBC A values, whereas there was no difference be- To the Editor: Carbohydrate-deficient transferrin (CDT) is currently the most specific laboratory marker of chronic alcohol abuse (1 ) . We report a 15-year-old boy with autoimmune hepatitis type 1, increased serum CDT, and no history of alcohol abuse. The case is particularly important because patients in the early phase of autoimmune hepatitis may be asymptomatic. The diagnostic criteria for autoimmune hepatitis (2 ), which were used for our patient, are summarized together with the patient's data in the Data Supplement that accompanies the online version of this letter at http://www.clinchem. org/content/vol49/issue6/.
The patient was admitted for evaluation of icterus ϳ1 week in duration, decreased performance, and fatigue for ϳ6 months. He had mild splenomegaly, and biopsy revealed developing micronodular cirrhosis. The patient's denial of alcohol intake was confirmed by his mother and by AUDIT (3 ) and MALT-F scores (4 ). One week before admission, the patient had herpes zoster treated successfully with Zovirax (orally) for 5 days. The patient had received no hepatotoxic medication and did not abuse drugs. Aspartate aminotransferase was increased ϳ30-fold, alanine aminotransferase 14-fold, bilirubin 8-fold, and direct bilirubin 27-fold. showed an abnormal transferrin isoform band pattern with increased amounts of disialo-Fe 2 -transferrin, which led to a decreased trisialo-/disialo-Fe 2 -transferrin peak height (area) ratio of 1.20 (Fig. 1, lane 3) compared with 2.2 for the healthy control (Fig. 1, lane 2) . Asialotransferrin, which is present with high prevalence in serum after chronic alcohol abuse (6 ) (Fig. 1,  lanes 1 and 4) and genetic transferrin variants were not detected in our patient's serum (Fig. 1, lane 3) . In summary, the IEF transferrin isoform band pattern for our patient confirmed the immunologic CDT results qualitatively but was not typical for chronic alcohol abuse.
We excluded the currently known clinical conditions for false-positive CDT results (1 ) as etiologies of our findings (see the Data Supplement). We know of no evidence that Zovirax alters transferrin glycosylation. Liver cirrhosis has been reported to increase CDT (7 ). In this study (7 ), this was most probably attributable to active viral hepatitis, which is known to increase serum CDT concentrations (1, 8 
